{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:14:48Z","timestamp":1774368888571,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jdiacomp.2009.01.005","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T20:52:05Z","timestamp":1238446325000},"page":"168-178","source":"Crossref","is-referenced-by-count":48,"title":["Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers"],"prefix":"10.1016","volume":"24","author":[{"given":"Amany A.","family":"Abdin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal A.","family":"Baalash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala E.","family":"Hamooda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2009.01.005_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/diacare.21.2.310","article-title":"Consensus development conference on insulin resistance: 5\u20136 November 1997","volume":"21","author":"American Diabetic Association","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-2007-978662","article-title":"Enhanced acute-phase response and oxidative stress in older adults with type II diabetes","volume":"32","author":"Arnalich","year":"2000","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2362.2000.00597.x","article-title":"Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans","volume":"30","author":"Baldeweg","year":"2000","journal-title":"European Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/j.jdiacomp.2009.01.005_bib4","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1210\/jc.85.9.3338","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss","volume":"85","author":"Bastard","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib5","first-page":"142","article-title":"Enzymatic determination of glucose","volume":"97","author":"Bdarham","year":"1972","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diabetes.46.1.3","article-title":"Role of fatty acids in the pathogenesis of insulin resistance and NIDDM","volume":"46","author":"Boden","year":"1997","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.jdiacomp.2009.01.005_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00291974","article-title":"Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man","volume":"28","author":"Bratusch-Marrain","year":"1985","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jdiacomp.2009.01.005_bib8","first-page":"280","article-title":"Effects of rosiglitazone and metformin on insulin resistance in high-fat diet rats","volume":"43","author":"Chen","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.24.2.195","article-title":"Aspirin therapy in diabetes is underutilized","volume":"24","author":"Colwell","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.01.005_bib10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.20.5.832","article-title":"Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM","volume":"20","author":"Contreras","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib11","series-title":"Ellenberg and Rifkin's Diabetes mellitus, theory and practice","first-page":"89","article-title":"B-cell function and insulin secretion","author":"Cook","year":"1996"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: The link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends in Immunology"},{"issue":"13","key":"10.1016\/j.jdiacomp.2009.01.005_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2165\/00003495-200363130-00004","article-title":"Thiazolidinediones in type 2 diabetes mellitus: Current clinical evidence","volume":"63","author":"Diamant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.316.7140.1303","article-title":"North of England evidence based guideline development project: Guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care","volume":"316","author":"Eccles","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","article-title":"Are oxidative stress-activated signaling pathways mediators of insulin resistance and \u03b2-cell dysfunction?","volume":"52","author":"Evans","year":"2003","journal-title":"Diabetes"},{"issue":"suppl","key":"10.1016\/j.jdiacomp.2009.01.005_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(00)00337-5","article-title":"The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"108","author":"Fujimoto","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/diacare.23.8.1108","article-title":"The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes","volume":"23","author":"Gabir","year":"2002","journal-title":"Diabetes Care"},{"issue":"27","key":"10.1016\/j.jdiacomp.2009.01.005_bib18","doi-asserted-by":"crossref","first-page":"24944","DOI":"10.1074\/jbc.M300423200","article-title":"Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases","volume":"278","author":"Gao","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.01.005_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1389450033490920","article-title":"Insulin resistance as a proinflammatory state: Mechanisms, mediators, and therapeutic interventions","volume":"4","author":"Garg","year":"2003","journal-title":"Curr Drug Targets"},{"issue":"9","key":"10.1016\/j.jdiacomp.2009.01.005_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.metabol.2004.03.014","article-title":"Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys","volume":"53","author":"Gee","year":"2004","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-61-1-160","article-title":"Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus","volume":"61","author":"Giugliano","year":"1985","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.jdiacomp.2009.01.005_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1185\/030079903125001695","article-title":"Are the metabolic effects of rosiglitazone influenced by baseline glycaemic control?","volume":"19","author":"Goldstein","year":"2003","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","article-title":"Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus","volume":"106","author":"Haffner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-2275(20)41609-8","article-title":"Amore sensitive and stable colorimetric determination of free fatty acids in blood","volume":"18","author":"Itaya","year":"1977","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib26","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/diacare.25.11.2022","article-title":"Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes","volume":"25","author":"Jayagopal","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1074\/jbc.M205565200","article-title":"Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor-\u03b1 (TNF-\u03b1) induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells","volume":"278","author":"Jiang","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1210\/jc.83.3.859","article-title":"Serum levels of tumor necrosis factor-\u03b1 are increased in obese patients with noninsulin-dependent diabetes mellitus","volume":"83","author":"Katsuki","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a116768","article-title":"How good a marker is insulin level for insulin resistance?","volume":"137","author":"Laakso","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.ATV.17.1.64","article-title":"Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators","volume":"17","author":"Laws","year":"1997","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(02)00371-4","article-title":"Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes","volume":"166","author":"Leinonen","year":"2003","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.01.005_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/er.23.2.201","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jcem-72-4-934","article-title":"Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities","volume":"72","author":"Lewis","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib34","unstructured":"Lobner K., and Fuchtenbusch M., (2004): Inflammation and diabetes. MMW Fortschr Med. 146(35-36):32\u20133, 35\u20136."},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.ATV.0000054195.35121.5E","article-title":"Antidiabetic PPAR\u03b3-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease","volume":"23","author":"Marx","year":"2003","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib36","first-page":"9","article-title":"Clinical evaluation of acetylsalicylic acid to improve glycemia in type II diabetic patients","volume":"39","author":"Mata-Segreda","year":"1989","journal-title":"Acta Physiologica et Pharmacologica Latinoamericana"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.01.005_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0149-2918(04)90017-3","article-title":"Progress with thiazolidinediones in the management of type 2 diabetes mellitus","volume":"26","author":"Meriden","year":"2004","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib38","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s001250100031","article-title":"Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type 2 diabetic patients","volume":"44","author":"Miyazaki","year":"2001","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jdiacomp.2009.01.005_bib39","first-page":"BR233","article-title":"Pentoxiyphilline as a cyclooxygenase (cox-2) inhibitor in experimental sepsis","volume":"10","author":"Modzelewski","year":"2004","journal-title":"Medical Science Monitor"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.01.005_bib40","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2003-032103","article-title":"Evidence for a potent antiinflammatory effect of rosiglitazone","volume":"89","author":"Mohanty","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/dmrr.321","article-title":"An adipocentric view of signaling and intracellular trafficking","volume":"18","author":"Mora","year":"2002","journal-title":"Diabetes Metabolism Research and Reviews"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib42","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.ATV.18.8.1199","article-title":"Relation between tumor necrosis factor- and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus","volume":"18","author":"Nilsson","year":"1998","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1345\/aph.1C101","article-title":"Aspirin dose for prevention of cardiovascular disease in diabetics","volume":"37","author":"Nowak","year":"2003","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diacare.27.1.77","article-title":"Fasting plasma free fatty acids and risk of type 2 diabetes","volume":"27","author":"Pankow","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.01.005_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/107175400266650","article-title":"Comparative effects of garlic and aspirin on diabetic cardiovascular complications","volume":"7","author":"Patumraj","year":"2000","journal-title":"Drug Delivery"},{"issue":"3","key":"10.1016\/j.jdiacomp.2009.01.005_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/13543784.13.3.215","article-title":"Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?","volume":"13","author":"Pershadsingh","year":"2004","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"3","key":"10.1016\/j.jdiacomp.2009.01.005_bib47","first-page":"171","article-title":"Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution","volume":"3","author":"Pickavance","year":"1999","journal-title":"BJP"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib48","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in types 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Science"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1172\/JCI113338","article-title":"Quantitative study of insulin secretion and clearance in normal and obese subjects","volume":"81","author":"Polonsky","year":"1988","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib51","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/diabetes.37.8.1020","article-title":"Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib52","first-page":"399","article-title":"Insulin antibody determination in theoretical and practical considerations","volume":"24","author":"Reaves","year":"1983","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.jdiacomp.2009.01.005_bib73","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/diabetes.44.9.1038","article-title":"Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin","volume":"44","author":"Rebrin","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib53","first-page":"E1286","article-title":"Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study","volume":"282","author":"Richardson","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2337\/diacare.24.2.197","article-title":"Aspirin use among adults with diabetes. Estimates from the third national health and nutrition examination survey","volume":"24","author":"Rolka","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib56","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(89)92804-3","article-title":"Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes","volume":"1","author":"Saad","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib57","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes. Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib59","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s001250051218","article-title":"Down regulation of peroxisome proliferator-activated receptor \u03b3 expression by inflammatory cytokines and its reversal by thiazolidinedione","volume":"42","author":"Tanaka","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib60","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/meta.2002.32804","article-title":"Subclinical inflammation is strongly related to insulin resistance but not insulin secretion in a high risk population for diabetes","volume":"51","author":"Temelkova-Kurktschiev","year":"2002","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2003-37493","article-title":"Aspirin and diabetes: inhibition of amylin aggregation by nonsteroidal anti-inflammatory drugs","volume":"111","author":"Thomas","year":"2003","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib62","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2337\/diabetes.44.8.863","article-title":"Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications","volume":"44","author":"Unger","year":"1995","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jdiacomp.2009.01.005_bib63","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s001250051000","article-title":"Elevated tumour necrosis factor alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and obesity","volume":"41","author":"Winkler","year":"1998","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.jdiacomp.2009.01.005_bib65","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of IKB kinase","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(94)90821-4","article-title":"Pathogenesis of non-insulin-dependent diabetes mellitus","volume":"343","author":"Yki-Jarvinen","year":"1994","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jdiacomp.2009.01.005_bib68","first-page":"1106","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"Drug Therapeutics"},{"key":"10.1016\/j.jdiacomp.2009.01.005_bib69","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1073\/pnas.0336385100","article-title":"Innate and acquired immunity intersect in a global view of the acute-phase response","volume":"100","author":"Yoo","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5535","key":"10.1016\/j.jdiacomp.2009.01.005_bib70","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk(beta)","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.01.005_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1538\/expanim.52.401","article-title":"The rat model of type 2 diabetic mellitus and its glycometabolism characters","volume":"52","author":"Zhang","year":"2003","journal-title":"Experimental Animmals"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.01.005_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3748\/wjg.v10.i1.77","article-title":"Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats","volume":"10","author":"Zhang","year":"2004","journal-title":"World Journal of Gastroenterology"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872709000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872709000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T19:09:06Z","timestamp":1633288146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872709000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1056872709000087"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2009.01.005","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}